| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Director | EVP &Chief Financial Officer +1 more
4 companies
Lee Sung is an EVP &Chief Financial Officer at VIR, with reported holdings spanning 4 companies. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $7.4M at current prices.
Lee Sung's largest disclosed position is in CYTK as EVP, Chief Financial Officer, worth about $5.6M. The recent filings there lean toward selling, a net 71,817 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | CYTK Cytokinetics, Incorporated | EVP, Chief Financial Officer | Sale+OE | 1,112 | $87.79 | $97,622.48 | -1.7% | -23.0% | - | |
| Jun 29, 2026 | CYTK Cytokinetics, Incorporated | EVP, Chief Financial Officer | Sale+OE | 3,134 | $85.00 | $266,390.00 | -4.7% | -24.2% | - | |
| Jun 24, 2026 | CYTK Cytokinetics, Incorporated | EVP, Chief Financial Officer | Sale+OE | 38,730 | $82.30 | $3,187,479.00 | -38.0% | -16.8% | - | |
| May 5, 2026 | CYTK Cytokinetics, Incorporated | EVP, Chief Financial Officer | Sell | 23,906 | $76.87 | $1,837,654.22 | -27.4% | -0.8% | - | |
| Mar 17, 2026 | CYTK Cytokinetics, Incorporated | EVP, Chief Financial Officer | Sell | 4,935 | $62.15 | $306,710.25 | -5.4% | +14.9% | - | |
| Mar 27, 2024 | VIR Vir Biotechnology, Inc. | EVP &Chief Financial Officer | Sell | 6,008 | $9.89 | $59,404.10 | -5.6% | -8.7% | -34.0% |